Eli Lilly & Co (NYSE: LLY) Q4 2020 earnings call dated Jan. 29, 2021
Corporate Participants:
Kevin Hern — Vice President of Investor Relations
David A. Ricks — Chairman and Chief Executive Officer
Joshua L. Smiley — Senior Vice President and Chief Financial Officer
Daniel M. Skovronsky — Senior Vice President and Chief Scientific Officer
Anne E. White — Senior Vice President and President of Lilly Oncology
Analysts:
Geoff Meacham — Bank of America — Analyst
Tim Anderson — Wolfe Research — Analyst
Umer Raffat — Evercore — Analyst
Steve Scala — Cowen and Company — Analyst
David Risinger — Morgan Stanley — Analyst
Daniel Ziment — Goldman Sachs — Analyst
Chris Schott — J.P. Morgan — Analyst
Seamus Fernandez — Guggenheim — Analyst
Andrew Baum — Citigroup — Analyst
Gregg Gilbert — Truist Securities — Analyst
Ronny Gal — Bernstein — Analyst
Vamil Divan — Mizuho Securities — Analyst
Carter Gould — Barclays — Analyst
Kerry Holford — Berenberg — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Key highlights from Deere & Co.’s (DE) Q4 2024 earnings results
Deere & Company (NYSE: DE) reported its fourth quarter 2024 earnings results today. Worldwide net sales and revenues decreased 28% year-over-year to $11.14 billion. Net income was $1.24 billion, or
NVDA Earnings: Nvidia Q3 profit jumps, beats estimates
NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a sharp increase in adjusted profit and revenue for the third quarter of 2025. Earnings also topped analysts' estimates. The tech firm’s revenues
Lowe’s Companies (LOW): A few points to note about the Q3 2024 performance
Shares of Lowe’s Companies, Inc. (NYSE: LOW) rose over 1% on Wednesday. The stock has gained 8% over the past three months. The company delivered better-than-expected earnings results for the
Listen On
